Shareholders of Google's parent Alphabet (NASDAQ: GOOGL)(NASDAQ: GOOG) are going through a rough patch. In the past year, Google lost two major antitrust cases aimed at the heart of its business ...

Revenue from Google’s mainstay ad business, which makes up about 75% of its overall revenue, rose 8.5% to $66.89 billion. The company also said it will buy back $70 billion stock.

Google parent Alphabet(NASDAQ: GOOG)(NASDAQ: GOOGL) is now the cheapest Magnificent Seven stock. But you might be surprised which stock ranks as the second-cheapest.

Alphabet is undervalued at a 17–18x forward P/E despite strong earnings and a dominant market position. Check out why I maintain a buy rating on GOOG stock.

While Alphabet’s stock performance in 2025 has been disappointing, the story is far from over. The company’s aggressive AI push, underscored by a strong showing at Google I/O, suggests it’s ...

Most investors are bullish on Alphabet/Google at these levels, but seem to overlook a very important risk. Check out the risk here and why GOOG stock is a Sell.

Google owner Alphabet will buy cybersecurity firm Wiz for $32 billion — in a deal set to boost the tech giant's in-house cloud computing amid burgeoning artificial intelligence growth.

Both Palantir Technologies (NASDAQ: PLTR) and Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) plan to capitalize on the artificial intelligence revolution, and already have to a certain extent. Palantir ...

Once considered Alphabet’s laggard, Google Cloud is now rapidly gaining ground. In Q1 2025, Google Cloud generated $12.26 billion in revenue, marking a 28% year-over-year increase.

On SEC-filed paper, Google ’s parent company, Alphabet, is in great shape. Every important part of its business is growing. It still owns the world’s main interface for the web.

In a scenario where OpenAI and its peers begin to erode Google search -- thereby taking a toll on Alphabet's advertising revenue -- Alphabet is still able to capture some downstream monetization.

Alphabet, Google’s parent company, is increasingly hiring from and investing in the biotechnology, healthcare and life sciences, according to CNBC.com. Here are three notes on the Mountain View ...